ALBANY, N.Y., Jan. 9, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the 32nd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2014 at 7:30 a.m. PT.
A webcast of the presentation can be accessed at the Investor Relations' section of www.amriglobal.com, or at the following URL:
http://jpmorgan.metameetings.com/confbook/healthcare14/directlink?ticker=AMRI. The webcast will be archived for 90 days following the live presentation.
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 22 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).